HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Domenico Coppola Selected Research

GFA 116

5/2004Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Domenico Coppola Research Topics

Disease

159Neoplasms (Cancer)
03/2022 - 02/2002
27Neoplasm Metastasis (Metastasis)
01/2021 - 04/2002
25Carcinogenesis
10/2021 - 10/2003
24Adenocarcinoma
10/2021 - 02/2002
22Colonic Neoplasms (Colon Cancer)
10/2021 - 04/2002
21Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 08/2002
18Breast Neoplasms (Breast Cancer)
10/2017 - 12/2003
17Pancreatic Neoplasms (Pancreatic Cancer)
02/2020 - 01/2003
14Carcinoma (Carcinomatosis)
11/2018 - 02/2002
13Prostatic Neoplasms (Prostate Cancer)
01/2022 - 09/2008
10Lung Neoplasms (Lung Cancer)
01/2020 - 03/2005
9Adenoma (Adenomas)
07/2018 - 04/2002
9Ovarian Epithelial Carcinoma
10/2015 - 08/2003
9Ovarian Neoplasms (Ovarian Cancer)
11/2012 - 04/2003
6Barrett Esophagus (Barrett's Esophagus)
01/2022 - 10/2007
6Neuroendocrine Tumors (Neuroendocrine Tumor)
08/2013 - 05/2006
5Inflammation (Inflammations)
01/2021 - 04/2002
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 01/2006
5Multiple Myeloma
01/2018 - 05/2011
4Stomach Neoplasms (Stomach Cancer)
01/2019 - 09/2016
4Esophageal Neoplasms (Esophageal Cancer)
01/2018 - 03/2004
4Carcinoid Tumor (Carcinoid)
03/2016 - 01/2006
4Lymphoma (Lymphomas)
11/2014 - 09/2003
4Colitis
11/2011 - 04/2002
4Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
12/2008 - 08/2002
4Melanoma (Melanoma, Malignant)
02/2007 - 06/2002
3Osteosarcoma (Osteogenic Sarcoma)
04/2019 - 09/2007
3Disease Progression
01/2019 - 01/2015
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2019 - 03/2004
3Adenocarcinoma of Lung
01/2019 - 11/2014
3Thyroid Neoplasms (Thyroid Cancer)
11/2018 - 07/2012
3Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2018 - 05/2011
3Leukemia
01/2018 - 09/2002
3Leiomyoma (Uterine Fibroids)
09/2007 - 07/2002

Drug/Important Bio-Agent (IBA)

50Proteins (Proteins, Gene)FDA Link
03/2022 - 04/2002
19Biomarkers (Surrogate Marker)IBA
03/2022 - 01/2009
14MicroRNAs (MicroRNA)IBA
01/2022 - 01/2008
13Phosphotransferases (Kinase)IBA
02/2020 - 03/2002
12Messenger RNA (mRNA)IBA
01/2022 - 07/2002
8Pharmaceutical PreparationsIBA
01/2022 - 12/2003
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 03/2002
7Coloring Agents (Dyes)IBA
03/2015 - 10/2003
6Androgen Receptors (Androgen Receptor)IBA
01/2022 - 09/2010
6LigandsIBA
01/2019 - 01/2006
6Nicotinamide PhosphoribosyltransferaseIBA
11/2018 - 06/2010
6RNA (Ribonucleic Acid)IBA
09/2018 - 04/2002
6Biological ProductsIBA
11/2014 - 04/2009
5CateninsIBA
01/2021 - 11/2015
5Vitamin EFDA LinkGeneric
01/2019 - 01/2009
5ErbB Receptors (EGF Receptor)IBA
03/2015 - 05/2011
5CytokinesIBA
11/2014 - 04/2002
5NicotineFDA Link
11/2014 - 01/2009
5Cisplatin (Platino)FDA LinkGeneric
07/2009 - 10/2002
5Insulin-Like PeptidesIBA
05/2006 - 01/2003
4Cadherins (E-Cadherin)IBA
01/2019 - 01/2009
4TocotrienolsIBA
01/2019 - 01/2013
4AndrogensIBA
12/2018 - 09/2010
4DNA (Deoxyribonucleic Acid)IBA
09/2018 - 06/2002
4Glycoproteins (Glycoprotein)IBA
01/2018 - 10/2004
4Tyrosine (L-Tyrosine)FDA Link
01/2018 - 03/2002
4TamoxifenFDA LinkGeneric
10/2016 - 11/2008
4CalciumIBA
11/2015 - 10/2004
4Epidermal Growth Factor (EGF)IBA
12/2010 - 08/2003
4Complementary DNA (cDNA)IBA
08/2010 - 01/2004
3EnzymesIBA
09/2021 - 07/2018
3Long Noncoding RNAIBA
03/2021 - 03/2015
3TransferasesIBA
04/2019 - 04/2009
3VimentinIBA
01/2019 - 01/2009
3Therapeutic UsesIBA
01/2019 - 08/2003
3Transforming Growth Factor beta (TGF-beta)IBA
01/2019 - 11/2008
3Protein Kinases (Protein Kinase)IBA
01/2019 - 10/2003
3Small Interfering RNA (siRNA)IBA
12/2018 - 07/2009
3Bortezomib (Velcade)FDA Link
01/2018 - 05/2011
3human ERBB2 proteinIBA
01/2018 - 04/2013
3Histones (Histone)IBA
12/2017 - 02/2011
3GemcitabineFDA Link
05/2017 - 07/2015
3Estrogen ReceptorsIBA
10/2016 - 12/2010
3ParaffinIBA
10/2016 - 03/2011
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2015 - 10/2003
3Peptides (Polypeptides)IBA
01/2015 - 01/2004
3SurvivinIBA
01/2015 - 01/2004
3Interleukin-6 (Interleukin 6)IBA
10/2014 - 01/2006
3Sirtuin 1IBA
11/2013 - 07/2009
3Tyrosine Kinase InhibitorsIBA
11/2011 - 09/2002
3Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
07/2011 - 01/2009
3triciribineIBA
05/2011 - 09/2007
3Carrier Proteins (Binding Protein)IBA
02/2011 - 04/2002
3Cyclin D1IBA
12/2008 - 03/2007
3Gefitinib (Iressa)FDA Link
08/2008 - 08/2003
3ascorbyl monostearate (ascorbyl stearate)IBA
11/2007 - 01/2003
3Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
10/2007 - 04/2003
3Interleukin-12 (IL 12)IBA
05/2006 - 06/2002
3CaspasesIBA
07/2005 - 08/2003

Therapy/Procedure

37Therapeutics
01/2022 - 08/2002
13Drug Therapy (Chemotherapy)
01/2020 - 03/2005
7Neoadjuvant Therapy
07/2021 - 03/2004
5Castration
12/2018 - 09/2010
4Immunotherapy
05/2018 - 06/2002
4Pancreatectomy
01/2016 - 10/2008
3Chemoprevention
01/2019 - 01/2007